1. Home
  2. PAYP vs NBIX Comparison

PAYP vs NBIX Comparison

Compare PAYP & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PAYP

PayPay Corporation American Depository Shares

N/A

Current Price

$20.43

Market Cap

12.9B

Sector

Real Estate

ML Signal

N/A

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$129.64

Market Cap

13.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAYP
NBIX
Founded
2018
1992
Country
Japan
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
13.9B
IPO Year
2026
1996

Fundamental Metrics

Financial Performance
Metric
PAYP
NBIX
Price
$20.43
$129.64
Analyst Decision
Buy
Strong Buy
Analyst Count
1
22
Target Price
$22.90
$175.27
AVG Volume (30 Days)
4.6M
868.5K
Earning Date
N/A
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
41.95
EPS
N/A
4.67
Revenue
N/A
$161,626,000.00
Revenue This Year
N/A
$22.85
Revenue Next Year
N/A
$9.99
P/E Ratio
N/A
$27.99
Revenue Growth
N/A
977.51
52 Week Low
$17.80
$84.23
52 Week High
$21.76
$160.18

Technical Indicators

Market Signals
Indicator
PAYP
NBIX
Relative Strength Index (RSI) N/A 46.03
Support Level N/A $128.03
Resistance Level N/A $136.74
Average True Range (ATR) 0.00 2.95
MACD 0.00 0.30
Stochastic Oscillator 0.00 35.47

Price Performance

Historical Comparison
PAYP
NBIX

About PAYP PayPay Corporation American Depository Shares

PayPay Corp is a Japan-based financial technology provider operating a digital finance platform that integrates payments, banking, credit, and investment services for individuals and businesses. Its platform connects users and merchants, facilitating a cashless ecosystem and providing an all-in-one solution for daily financial activities. The company operates in two reportable segments: i) Payment segment and ii) Financial service segment. The majority of the company's revenue is derived from the Financial service segment, which includes internet banking services, securities intermediary services and PayPay Point investment-related services, and loan management services. Geographically, it operates predominantly in Japan.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Share on Social Networks: